140 related articles for article (PubMed ID: 36123540)
21. Prognostic predictions based on pathological findings of peritoneal dissemination in patients with stage IV colorectal cancer without residual disease (R0 status).
Komori K; Kinoshita T; Oshiro T; Ouchi A; Ito S; Abe T; Senda Y; Misawa K; Ito Y; Natsume S; Higaki E; Okuno M; Hosoi T; An B; Hayashi D; Uchino T; Kunitomo A; Oki S; Takano J; Suenaga Y; Maeda S; Dei H; Numata Y; Shimizu Y
Surg Today; 2019 Sep; 49(9):755-761. PubMed ID: 30963344
[TBL] [Abstract][Full Text] [Related]
22. pT4 stage II and III colon cancers carry the worst prognosis in a nationwide survival analysis. Shepherd's local peritoneal involvement revisited.
Snaebjornsson P; Coupe VM; Jonasson L; Meijer GA; van Grieken NC; Jonasson JG
Int J Cancer; 2014 Jul; 135(2):467-78. PubMed ID: 24347179
[TBL] [Abstract][Full Text] [Related]
23. Postoperative abdominal infections after resection of T4 colon cancer increase the risk of intra-abdominal recurrence.
Klaver CEL; Wasmann KATGM; Verstegen M; van der Bilt JDW; Nagtegaal ID; van Ramshorst B; Tanis PJ; Wolthuis AM; van Santvoort HC; de Wilt JHW; D'Hoore A
Eur J Surg Oncol; 2018 Dec; 44(12):1880-1888. PubMed ID: 30360990
[TBL] [Abstract][Full Text] [Related]
24. Are "micrometastases" of the peritoneum equivalent to distant metastases?
Kienle P; Koch M
Dig Surg; 2002; 19(6):453-8. PubMed ID: 12499736
[TBL] [Abstract][Full Text] [Related]
25. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
Narasimhan V; Britto M; Pham T; Warrier S; Naik A; Lynch AC; Michael M; Tie J; Ramsay R; Heriot A
Dis Colon Rectum; 2019 Oct; 62(10):1195-1203. PubMed ID: 31490828
[TBL] [Abstract][Full Text] [Related]
26. [Application of laparoscopic exploration combined with abdominal exfoliative cytology in the diagnosis and treatment of locally advanced gastric cancer].
Ding PA; Liu Y; Guo HH; Yang PG; Tian Y; Fan LQ; Tan BB; Li Y; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):170-176. PubMed ID: 32074798
[No Abstract] [Full Text] [Related]
27. Special cancer microenvironment in human colonic cancer: Concept of cancer microenvironment formed by peritoneal invasion (CMPI) and implication of subperitoneal fibroblast in cancer progression.
Kojima M; Ochiai A
Pathol Int; 2016 Mar; 66(3):123-131. PubMed ID: 26816328
[TBL] [Abstract][Full Text] [Related]
28. The Prognostic Relevance of Histological Subtype in Patients With Peritoneal Metastases From Colorectal Cancer: A Nationwide Population-Based Study.
Razenberg LG; van Gestel YR; Lemmens VE; de Wilt JH; Creemers GJ; de Hingh IH
Clin Colorectal Cancer; 2015 Dec; 14(4):e13-9. PubMed ID: 26140733
[TBL] [Abstract][Full Text] [Related]
29. CD133 expression predicts post-operative recurrence in patients with colon cancer with peritoneal metastasis.
Nagata H; Ishihara S; Kishikawa J; Sonoda H; Murono K; Emoto S; Kaneko M; Sasaki K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Hata K; Kawai K; Nozawa H
Int J Oncol; 2018 Mar; 52(3):721-732. PubMed ID: 29328371
[TBL] [Abstract][Full Text] [Related]
30. Patients with extensive regional lymph node involvement (pN2) following potentially curative surgery for colorectal cancer are at increased risk for developing peritoneal metastases: a retrospective single-institution study.
Bhatt A; Bhamre R; Rohila J; Kalikar V; Desouza A; Saklani A
Colorectal Dis; 2019 Mar; 21(3):287-296. PubMed ID: 30457185
[TBL] [Abstract][Full Text] [Related]
31. Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP-PRODIGE 15): a randomised, phase 3 study.
Goéré D; Glehen O; Quenet F; Guilloit JM; Bereder JM; Lorimier G; Thibaudeau E; Ghouti L; Pinto A; Tuech JJ; Kianmanesh R; Carretier M; Marchal F; Arvieux C; Brigand C; Meeus P; Rat P; Durand-Fontanier S; Mariani P; Lakkis Z; Loi V; Pirro N; Sabbagh C; Texier M; Elias D;
Lancet Oncol; 2020 Sep; 21(9):1147-1154. PubMed ID: 32717180
[TBL] [Abstract][Full Text] [Related]
32. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management.
Pestieau SR; Sugarbaker PH
Dis Colon Rectum; 2000 Oct; 43(10):1341-6; discussion 1347-8. PubMed ID: 11052509
[TBL] [Abstract][Full Text] [Related]
33. Gastrointestinal perforation in metastatic colorectal cancer patients with peritoneal metastases receiving bevacizumab.
Roohullah A; Wong HL; Sjoquist KM; Gibbs P; Field K; Tran B; Shapiro J; Mckendrick J; Yip D; Nott L; Gebski V; Ng W; Chua W; Price T; Tebbutt N; Chantrill L
World J Gastroenterol; 2015 May; 21(17):5352-8. PubMed ID: 25954110
[TBL] [Abstract][Full Text] [Related]
34. Free colorectal cancer cells on the peritoneal surface: correlation with pathologic variables and survival.
Baskaranathan S; Philips J; McCredden P; Solomon MJ
Dis Colon Rectum; 2004 Dec; 47(12):2076-9. PubMed ID: 15657657
[TBL] [Abstract][Full Text] [Related]
35. Development of a risk-scoring system to evaluate the serosal invasion for macroscopic serosal invasion positive gastric cancer patients.
Wang PL; Huang JY; Zhu Z; Gong BC; Huang HW; Duan SJ; Xu HM; Liu FN
Eur J Surg Oncol; 2018 May; 44(5):600-606. PubMed ID: 29454557
[TBL] [Abstract][Full Text] [Related]
36. LGR5 expression predicts peritoneal recurrence after curative resection of primary colon cancer.
Nagata H; Ishihara S; Abe H; Ushiku T; Kishikawa J; Tanaka T; Hata K; Kawai K; Fukayama M; Nozawa H
Br J Cancer; 2019 May; 120(10):996-1002. PubMed ID: 31000786
[TBL] [Abstract][Full Text] [Related]
37. Carcinoembryonic antigen and matrix metalloproteinase 2 serum and peritoneal washes concentration in staging and prognosis in colorectal cancer patients.
Guzel T; Mirowska-Guzel D; Lech G; Wroński M; Iwanowska M; Słodkowski M
Pol Przegl Chir; 2018 Jun; 90(5):36-43. PubMed ID: 30426942
[TBL] [Abstract][Full Text] [Related]
38. Positive peritoneal washing cytology is a potential risk factor for the recurrence of curatively resected colorectal cancer.
Homma Y; Hamano T; Akazawa Y; Otsuki Y; Shimizu S; Kobayashi H; Kameoka S; Kobayashi Y
Surg Today; 2014 Jun; 44(6):1084-9. PubMed ID: 23942820
[TBL] [Abstract][Full Text] [Related]
39. Should a History of Extraperitoneal Disease Be a Contraindication to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases?
Baratti D; Kusamura S; Iusco D; Cotsoglou C; Guaglio M; Battaglia L; Virzì S; Mazzaferro V; Deraco M
Dis Colon Rectum; 2018 Sep; 61(9):1026-1034. PubMed ID: 30086051
[TBL] [Abstract][Full Text] [Related]
40. [Rationality of performing hyperthermic intraperitoneal chemotherapy 5-8 weeks after primary tumor resection for patients with locally advanced colorectal cancer-based on COLOPEC].
Lei ZY; Guan TP; Luo JL; Tang HS; Cui SZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Dec; 22(12):1115-1117. PubMed ID: 31874525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
